What this covers
CLAIR screens selected disclosures of Singapore-incorporated listed companies, followed by officer validation. Its current scope covers impairment and fair value. A DAL goes to the board and does not require a response to ACRA.
How to use this guidance
Assess observations with auditors using company facts and materiality. A DAL is separate from FRSP, although potential material non-compliance may be escalated. No observation on another standard does not mean ACRA has reviewed or approved it.
Official source
A concise, independent Apex Gateway guide based on the official English source, not a reproduction of the complete document. Consult the original for full conditions, exceptions and subsequent updates.
Read the official source ↗